For patients with bacterial skin infections, you want to provide safe, continuous relief — with rapid speed of onset and first-time treatment success.
That relief also gives pet owners peace of mind. Ninety-six percent of pet owners said they would use CONVENIA® (cefovecin sodium) again if their veterinarian recommended it.5
A single injection offers:
Rapid speed of onset Clinical signs of infection may begin to show improvement within hours after an injection.
Duration of relief Provides up to 14 days of antibiotic therapy.3,4
Proven efficacy Gives your patients effective treatment of common bacterial skin infections.3,4
In clinical studies:
Four safety and efficacy studies showed: A single 8 mg/kg (3.6 mg/lb) injection of cefovecin sodium was effective and safe in treating bacterial skin infections in dogs3,8,9 and cats.4
Additional pharmacokinetic studies in dogs1 and in cats2 showed: Cefovecin has the ideal pharmacokinetic-pharmacodynamic characteristics for time-dependent antimicrobial.
Field efficacy studies in dogs & cats
In field efficacy studies, a single CONVENIA injection was clinically equivalent in efficacy to a 14-day course of an oral cephalosporin in treating bacterial skin infections in dogs3 and cats.4
Field efficacy study: dogs3
Results
A single injection of CONVENIA at 8 mg/kg (3.6 mg/lb) administered subcutaneously, which could be repeated once after 14 days, was effective against naturally occurring infections in dogs.
Study design
In a double-blind multicenter study of dogs diagnosed with naturally occurring skin infections:
235 enrolled client-owned dogs were evaluated for efficacy.
Each infection was confirmed by bacterial culture.
Half of patients received saline injection followed by a 14-day course of cefadroxil.
Half of patients received CONVENIA followed by a 14-day course of placebo tablets.
A total of two 14-day treatment courses were permitted.
Dogs were evaluated on days 0, 7, 14 and 28 if administered 1 treatment course. If a second treatment was given of either CONVENIA or cefadroxil, dogs were also evaluated at day 42.
In a double-blind multicenter study of dogs diagnosed with naturally occurring skin infections:
235 enrolled client-owned dogs were evaluated for efficacy.
Each infection was confirmed by bacterial culture.
Half of patients received saline injection followed by a 14-day course of cefadroxil.
Half of patients received CONVENIA followed by a 14-day course of placebo tablets.
A total of two 14-day treatment courses were permitted.
Dogs were evaluated on days 0, 7, 14 and 28 if administered 1 treatment course. If a second treatment was given of either CONVENIA or cefadroxil, dogs were also evaluated at day 42.
Field efficacy study: cats4
Results
A single injection of CONVENIA at 8 mg/kg (3.6 mg/lb) administered subcutaneously was effective against naturally occurring infections in cats.
Study design
In a double-blind multicenter study of cats diagnosed with naturally occurring skin infections:
291 cats were enrolled.
Each infection was confirmed by bacterial culture.
Half of patients received saline injection followed by a 14-day course of cefadroxil.
Half of patients received CONVENIA followed by a 14-day course of placebo tablets.
One 14-day treatment course was permitted.
Cats were evaluated on days 0, 7, 14 and 28.
In a double-blind multicenter study of dogs diagnosed with naturally occurring skin infections:
291 cats were enrolled.
Each infection was confirmed by bacterial culture.
Half of patients received saline injection followed by a 14-day course of cefadroxil.
Half of patients received CONVENIA followed by a 14-day course of placebo tablets.
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
For animals. For health. For you.
This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.
United States 
